GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 213 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $19,952,000 | +53.4% | 251,000 | -6.4% | 0.64% | +20.2% |
| Q3 2019 | $13,008,000 | +5.2% | 268,100 | +14.1% | 0.53% | +19.4% |
| Q2 2019 | $12,361,000 | +399.0% | 235,000 | +37.1% | 0.44% | +335.3% |
| Q4 2016 | $2,477,000 | -37.3% | 171,428 | 0.0% | 0.10% | -44.6% |
| Q3 2016 | $3,951,000 | -86.3% | 171,428 | -90.1% | 0.18% | -83.7% |
| Q2 2016 | $28,764,000 | +51.9% | 1,733,828 | +45.2% | 1.13% | +40.2% |
| Q1 2016 | $18,934,000 | -49.7% | 1,193,811 | +2.6% | 0.81% | -47.1% |
| Q4 2015 | $37,626,000 | +0.2% | 1,163,811 | +30.7% | 1.52% | +5.0% |
| Q3 2015 | $37,549,000 | – | 890,620 | – | 1.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |